The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Clinical and patient‐reported outcomes of SPARE – a randomised feasibility study of selective bladder preservation versus radical cystectomy
Open accessAbstract
Objectives: To test the feasibility of a randomised trial in muscle‐invasive bladder cancer ( MIBC ) and compare outcomes in patients who receive neoadjuvant chemotherapy followed by radical cystectomy ( RC ) or selective bladder preservation ( SBP ), where definitive treatment [ RC or radiotherapy ( RT )] is determined by response to chemotherapy. Patients and Methods: SPARE is a multicentre randomised controlled trial comparing RC and SBP in patients with MIBC staged T2–3 N0 M0, fit for both treatment strategies and receiving three cycles of neoadjuvant chemotherapy. Patients were randomised between RC and SBP before a cystoscopy after cycle three of neoadjuvant chemotherapy. Patients with ≤T1 residual tumour received a fourth cycle of neoadjuvant chemotherapy in both groups, followed by radical RT in the SBP group and RC in in the RC group; non‐responders in both groups proceeded immediately to RC following cycle three. Feasibility study primary endpoints were accrual rate and compliance with assigned treatment strategy. The phase III trial was designed to demonstrate non‐inferiority of SBP in terms of overall survival ( OS ) in patients whose tumours responded to neoadjuvant chemotherapy. Secondary endpoints included patient‐reported quality of life, clinician assessed toxicity, loco‐regional recurrence‐free survival, and rate of salvage RC after SBP . Results: Trial recruitment was challenging and below the predefined target with 45 patients recruited in 30 months (25 RC ; 20 SBP ). Non‐compliance with assigned treatment strategy was frequent, six of the 25 patients (24%) randomised to RC received RT . Long‐term bladder preservation rate was 11/15 (73%) in those who received RT per protocol. OS survival was not significantly different between groups. Conclusions: Randomising patients with MIBC between RC and SBP based on response to neoadjuvant chemotherapy was not feasible in the UK health system. Strong clinician and patient preferences for treatments impacted willingness to undergo randomisation and acceptance of treatment allocation. Due to the few participants, firm conclusions about disease and toxicity outcomes cannot be drawn.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Cited by
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Patel, V. G., Oh, W. K., & Galsky, M. D. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21631 · Cited by 1,014
Metadata
- Authors
- Huddart, R. A., Birtle, A., Maynard, L., Beresford, M., Blazeby, J., Donovan, J., Kelly, J. D., Kirkbank, T., McLaren, D. B., Mead, G., Moynihan, C., Persad, R., Scrase, C., Lewis, R., & Hall, E.
- Venue
- BJU International
- Publisher
- Wiley
- Published
- 2017-05-29
- Volume
- 120
- Issue
- 5
- Pages
- 639-650
- ISSN
- 1464-4096 (ISSN-L)
- 1464-410X
- OpenAlex
- W2607756307
- Cited by
- 172
- References
- 1
- FWCI
- 11.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical and patient‐reported outcomes of SPARE – a randomised feasibility study of selective bladder preservation versus radical cystectomy. https://app.cochat.ai/papers/10.1111/bju.13900
- The paper
- Huddart, R. A., Birtle, A., Maynard, L., Beresford, M., Blazeby, J., Donovan, J., Kelly, J. D., Kirkbank, T., McLaren, D. B., Mead, G., Moynihan, C., Persad, R., Scrase, C., Lewis, R., & Hall, E. (2017). Clinical and patient‐reported outcomes of SPARE – a randomised feasibility study of selective bladder preservation versus radical cystectomy. BJU International. https://doi.org/10.1111/bju.13900
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.